Plasma sample collection for head and neck squamous cancer
Part of Cancer clinical trials.
This study collects blood plasma samples from people with squamous cell cancer of the head and neck. Researchers want to better understand how treatments work, based on your prior cancer therapy, which may help future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been treated for squamous cell cancer in the head and neck
- You received radiation therapy plus cetuximab (an anti-cancer antibody)
- You received cetuximab either with chemotherapy or as part of specific cancer treatment plans
- You have also been treated with a targeted therapy (medicine aimed at cancer targets) as part of a clinical study
- Your cancer is not a different type of head and neck cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
This trial is collecting information and blood samples from people with head and neck cancer that cannot be cured. It aims to learn more about the cancer and find better ways to treat it.
This study tests an optimized plan for treating squamous cell cancer in the head and neck area using curative treatment that includes chemotherapy with cisplatin plus radiation after surgery. It may help doctors improve early management and outcomes for people eligible for this standard approach.
This trial collects tumor samples from people with head and neck squamous cell cancer to study why some cancers stop responding to standard treatments like cetuximab. The goal is to learn how resistance develops so better therapies can be found.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
This study looks at specific genetic “methylation” patterns in people with head and neck squamous cell carcinoma. The results may help doctors understand the disease better and identify who may benefit from future treatments.
Hear when a new Squamous Cell Carcinoma of the Head and Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.